Douglas Jolly
2018
In 2018, Douglas Jolly earned a total compensation of $623.1K as Executive Vice President, Research and Pharmaceutical Development at Forte Biosciences, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,699 |
|---|---|
| Option Awards | $206,192 |
| Salary | $297,019 |
| Other | $150 |
| Total | $623,060 |
Jolly received $297K in salary, accounting for 48% of the total pay in 2018.
Jolly also received $119.7K in non-equity incentive plan, $206.2K in option awards and $150 in other compensation.
Rankings
In 2018, Douglas Jolly's compensation ranked 11,143rd out of 14,244 executives tracked by ExecPay. In other words, Jolly earned more than 21.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,143 out of 14,244 | 22nd |
Division Manufacturing | 4,502 out of 5,765 | 22nd |
Major group Chemicals And Allied Products | 1,706 out of 2,128 | 20th |
Industry group Drugs | 1,446 out of 1,817 | 20th |
Industry Pharmaceutical Preparations | 1,109 out of 1,391 | 20th |
Source: SEC filing on April 19, 2019.
Jolly's colleagues
We found three more compensation records of executives who worked with Douglas Jolly at Forte Biosciences in 2018.